Search Result

Results for "

miRNA

" in MedChemExpress (MCE) Product Catalog:

By Targets:	MicroRNA (9996) Apoptosis (1) Bcl-2 Family (1) CDK (1) HDAC (1) NF-κB (1)
By Research Areas:	Cancer (9980) Inflammation/Immunology (1) Neurological Disease (1)
Oligonucleotides:	miRNA mimics (784) miRNA antagomirs (4605) MicroRNAs (9995) miRNA inhibitors (4606)

9999

Inhibitors & Agonists

Screening Libraries

MCE Kits

9995

Oligonucleotides

Targets Recommended: MicroRNA

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-152173

HDAC-IN-51	HDAC Apoptosis Bcl-2 Family CDK	Cancer
HDAC-IN-51 is a potent histone deacetylase (HDAC) inhibitor with IC₅₀ values of 0.32, 0.353, 0.431, 0.515, and 85.4 μM for HDAC10, HDAC1, HDAC2, HDAC3 and HDAC11, respectively. HDAC-IN-51 induces cell cycle arrest and apoptosis, modulating cell cycle-/apoptosis-related miRNAs expression. HDAC-IN-51 can be used in research of cancer .

HY-155237

LIN28-IN-1	Others	Cancer
LIN28-IN-1 (compound 5) is an inhibitor of the RNA-binding and regulatory protein LIN28 and binds to the LIN28 cold shock domain (CSD). LIN28-IN-1 effectively inhibits the interaction between LIN28 and let-7 miRNA (IC₅₀: 5.4 μM), blocking the negative impact of LIN28 on epigenetic gene regulation. LIN28-IN-1 significantly inhibits the proliferation of JAR cancer cells expressing LIN28 (IC₅₀: 6.4 μM) .

HY-120269

CAY10512	NF-κB	Neurological Disease Inflammation/Immunology
CAY10512 is an inhibitor of NF-κB. CAY10512 can suppress the upregulation of NF-κB-sensitive proinflammatory miRNAs (miRNA-9, miRNA-125b, miRNA-146a, miRNA-155) in cerebrospinal fluid and extracellular fluid, and can be used for research on Alzheimer's disease .

HY-RI00019

hsa-miR-10226 inhibitor	MicroRNA	Cancer
hsa-miR-10226 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-10226 inhibitor hsa-miR-10226 inhibitor

HY-RI00057

hsa-miR-107 inhibitor	MicroRNA	Cancer
hsa-miR-107 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-107 inhibitor hsa-miR-107 inhibitor

HY-RI00064

hsa-miR-11399 inhibitor	MicroRNA	Cancer
hsa-miR-11399 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-11399 inhibitor hsa-miR-11399 inhibitor

HY-RI00065

hsa-miR-11400 inhibitor	MicroRNA	Cancer
hsa-miR-11400 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-11400 inhibitor hsa-miR-11400 inhibitor

HY-RI00066

hsa-miR-11401 inhibitor	MicroRNA	Cancer
hsa-miR-11401 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-11401 inhibitor hsa-miR-11401 inhibitor

HY-RI00069

hsa-miR-1179 inhibitor	MicroRNA	Cancer
hsa-miR-1179 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1179 inhibitor hsa-miR-1179 inhibitor

HY-RI00072

hsa-miR-1182 inhibitor	MicroRNA	Cancer
hsa-miR-1182 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1182 inhibitor hsa-miR-1182 inhibitor

HY-RI00073

hsa-miR-1183 inhibitor	MicroRNA	Cancer
hsa-miR-1183 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1183 inhibitor hsa-miR-1183 inhibitor

HY-RI00074

hsa-miR-1184 inhibitor	MicroRNA	Cancer
hsa-miR-1184 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1184 inhibitor hsa-miR-1184 inhibitor

HY-RI00078

hsa-miR-1193 inhibitor	MicroRNA	Cancer
hsa-miR-1193 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1193 inhibitor hsa-miR-1193 inhibitor

HY-RI00079

hsa-miR-1197 inhibitor	MicroRNA	Cancer
hsa-miR-1197 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1197 inhibitor hsa-miR-1197 inhibitor

HY-RI00082

hsa-miR-1202 inhibitor	MicroRNA	Cancer
hsa-miR-1202 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1202 inhibitor hsa-miR-1202 inhibitor

HY-RI00083

hsa-miR-1203 inhibitor	MicroRNA	Cancer
hsa-miR-1203 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1203 inhibitor hsa-miR-1203 inhibitor

HY-RI00084

hsa-miR-1204 inhibitor	MicroRNA	Cancer
hsa-miR-1204 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1204 inhibitor hsa-miR-1204 inhibitor

HY-RI00085

hsa-miR-1205 inhibitor	MicroRNA	Cancer
hsa-miR-1205 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1205 inhibitor hsa-miR-1205 inhibitor

HY-RI00088

hsa-miR-1208 inhibitor	MicroRNA	Cancer
hsa-miR-1208 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1208 inhibitor hsa-miR-1208 inhibitor

HY-RI00089

hsa-miR-12113 inhibitor	MicroRNA	Cancer
hsa-miR-12113 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12113 inhibitor hsa-miR-12113 inhibitor

HY-RI00090

hsa-miR-12114 inhibitor	MicroRNA	Cancer
hsa-miR-12114 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12114 inhibitor hsa-miR-12114 inhibitor

HY-RI00091

hsa-miR-12115 inhibitor	MicroRNA	Cancer
hsa-miR-12115 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12115 inhibitor hsa-miR-12115 inhibitor

HY-RI00092

hsa-miR-12116 inhibitor	MicroRNA	Cancer
hsa-miR-12116 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12116 inhibitor hsa-miR-12116 inhibitor

HY-RI00093

hsa-miR-12117 inhibitor	MicroRNA	Cancer
hsa-miR-12117 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12117 inhibitor hsa-miR-12117 inhibitor

HY-RI00094

hsa-miR-12118 inhibitor	MicroRNA	Cancer
hsa-miR-12118 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12118 inhibitor hsa-miR-12118 inhibitor

HY-RI00095

hsa-miR-12119 inhibitor	MicroRNA	Cancer
hsa-miR-12119 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12119 inhibitor hsa-miR-12119 inhibitor

HY-RI00096

hsa-miR-12120 inhibitor	MicroRNA	Cancer
hsa-miR-12120 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12120 inhibitor hsa-miR-12120 inhibitor

HY-RI00097

hsa-miR-12121 inhibitor	MicroRNA	Cancer
hsa-miR-12121 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12121 inhibitor hsa-miR-12121 inhibitor

HY-RI00098

hsa-miR-12122 inhibitor	MicroRNA	Cancer
hsa-miR-12122 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12122 inhibitor hsa-miR-12122 inhibitor

HY-RI00099

hsa-miR-12123 inhibitor	MicroRNA	Cancer
hsa-miR-12123 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12123 inhibitor hsa-miR-12123 inhibitor

HY-RI00100

hsa-miR-12124 inhibitor	MicroRNA	Cancer
hsa-miR-12124 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12124 inhibitor hsa-miR-12124 inhibitor

HY-RI00101

hsa-miR-12125 inhibitor	MicroRNA	Cancer
hsa-miR-12125 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12125 inhibitor hsa-miR-12125 inhibitor

HY-RI00102

hsa-miR-12126 inhibitor	MicroRNA	Cancer
hsa-miR-12126 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12126 inhibitor hsa-miR-12126 inhibitor

HY-RI00103

hsa-miR-12127 inhibitor	MicroRNA	Cancer
hsa-miR-12127 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12127 inhibitor hsa-miR-12127 inhibitor

HY-RI00104

hsa-miR-12128 inhibitor	MicroRNA	Cancer
hsa-miR-12128 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12128 inhibitor hsa-miR-12128 inhibitor

HY-RI00105

hsa-miR-12129 inhibitor	MicroRNA	Cancer
hsa-miR-12129 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12129 inhibitor hsa-miR-12129 inhibitor

HY-RI00106

hsa-miR-12130 inhibitor	MicroRNA	Cancer
hsa-miR-12130 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12130 inhibitor hsa-miR-12130 inhibitor

HY-RI00107

hsa-miR-12131 inhibitor	MicroRNA	Cancer
hsa-miR-12131 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12131 inhibitor hsa-miR-12131 inhibitor

HY-RI00108

hsa-miR-12132 inhibitor	MicroRNA	Cancer
hsa-miR-12132 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12132 inhibitor hsa-miR-12132 inhibitor

HY-RI00109

hsa-miR-12133 inhibitor	MicroRNA	Cancer
hsa-miR-12133 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12133 inhibitor hsa-miR-12133 inhibitor

HY-RI00110

hsa-miR-12135 inhibitor	MicroRNA	Cancer
hsa-miR-12135 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12135 inhibitor hsa-miR-12135 inhibitor

HY-RI00111

hsa-miR-12136 inhibitor	MicroRNA	Cancer
hsa-miR-12136 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-12136 inhibitor hsa-miR-12136 inhibitor

HY-RI00127

hsa-miR-1231 inhibitor	MicroRNA	Cancer
hsa-miR-1231 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1231 inhibitor hsa-miR-1231 inhibitor

HY-RI00137

hsa-miR-1243 inhibitor	MicroRNA	Cancer
hsa-miR-1243 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1243 inhibitor hsa-miR-1243 inhibitor

HY-RI00139

hsa-miR-1244 inhibitor	MicroRNA	Cancer
hsa-miR-1244 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1244 inhibitor hsa-miR-1244 inhibitor

HY-RI00144

hsa-miR-1246 inhibitor	MicroRNA	Cancer
hsa-miR-1246 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1246 inhibitor hsa-miR-1246 inhibitor

HY-RI00147

hsa-miR-1248 inhibitor	MicroRNA	Cancer
hsa-miR-1248 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1248 inhibitor hsa-miR-1248 inhibitor

HY-RI00156

hsa-miR-1253 inhibitor	MicroRNA	Cancer
hsa-miR-1253 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1253 inhibitor hsa-miR-1253 inhibitor

HY-RI00160

hsa-miR-1256 inhibitor	MicroRNA	Cancer
hsa-miR-1256 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1256 inhibitor hsa-miR-1256 inhibitor

HY-RI00161

hsa-miR-1257 inhibitor	MicroRNA	Cancer
hsa-miR-1257 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1257 inhibitor hsa-miR-1257 inhibitor